<- Go Home
Proteina Co., Ltd.
Proteina Co., Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.
Market Cap
N/A
Volume
N/A
Cash and Equivalents
N/A
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
N/A
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
N/A
Debt
N/A
Equity
N/A
Revenue
N/A
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A